Background: Previous studies rarely evaluated the associations between
vitamin D-binding protein and free
vitamin D with
colorectal cancer risk. We assessed these
biomarkers and total
25-hydroxyvitamin D in relation to
colorectal cancer risk in a sample of African Americans.Methods: Cases comprised 224 African American participants of the Southern Community Cohort Study diagnosed with incident
colorectal cancer. Controls (N = 440) were selected through incidence density sampling and matched to cases on age, sex, and race. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for associations between
biomarker levels and
colorectal cancer risk.Results:
Vitamin D was inversely associated with
colorectal cancer risk where the OR per-SD increase in total and free
25-hydroxyvitamin D were 0.82 (95% CI, 0.66-1.02) and 0.82 (95% CI, 0.66-1.01), respectively. Associations were most apparent among cases diagnosed >3 years after blood draw:
ORs for the highest tertile versus the lowest were 0.69 (95% CI, 0.21-0.93) for total
25-hydroxyvitamin D and 0.71 (95% CI, 0.53-0.97) for free
25-hydroxyvitamin D. Inverse associations were seen in strata defined by sex, BMI, and anatomic site, although not all findings were statistically significant.
Vitamin D-binding protein was not associated with
colorectal cancer risk.Conclusions: Our findings suggest that total and free
25-hydroxyvitamin D may be inversely associated with
colorectal cancer risk among African Americans.Impact: These findings highlight a potential role for
vitamin D in
colorectal cancer prevention in African Americans.
Cancer Epidemiol
Biomarkers Prev; 26(8); 1242-7. ©2017 AACR.